The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors

(1) Background: The N-methyl-D-aspartate receptors (NMDARs) mediate fast excitatory currents leading to depolarization. Postsynaptic NMDARs are ionotropic glutamate receptors that mediate excitatory glutamate or glycine signaling in the CNS and play a primary role in long-term potentiation, which is...

Full description

Bibliographic Details
Main Authors: Shinhui Lee, Sanung Eom, Khoa V. A. Nguyen, Jiwon Lee, Youngseo Park, Hye Duck Yeom, Junho H. Lee
Format: Article
Language:English
Published: MDPI AG 2022-07-01
Series:Antioxidants
Subjects:
Online Access:https://www.mdpi.com/2076-3921/11/8/1471
_version_ 1827618203150319616
author Shinhui Lee
Sanung Eom
Khoa V. A. Nguyen
Jiwon Lee
Youngseo Park
Hye Duck Yeom
Junho H. Lee
author_facet Shinhui Lee
Sanung Eom
Khoa V. A. Nguyen
Jiwon Lee
Youngseo Park
Hye Duck Yeom
Junho H. Lee
author_sort Shinhui Lee
collection DOAJ
description (1) Background: The N-methyl-D-aspartate receptors (NMDARs) mediate fast excitatory currents leading to depolarization. Postsynaptic NMDARs are ionotropic glutamate receptors that mediate excitatory glutamate or glycine signaling in the CNS and play a primary role in long-term potentiation, which is a major form of use-dependent synaptic plasticity. The overstimulation of NMDARs mediates excessive Ca<sup>2+</sup> influx to postsynaptic neurons and facilitates more production of ROS, which induces neuronal apoptosis. (2) Methods: To confirm the induced inward currents by the coapplication of glutamate and ergotamine on NMDARs, a two-electrode voltage clamp (TEVC) was conducted. The ergotamine-mediated inhibitory effects of NR1a/NR2A subunits were explored among four different kinds of recombinant NMDA subunits. In silico docking modeling was performed to confirm the main binding site of ergotamine. (3) Results: The ergotamine-mediated inhibitory effect on the NR1a/NR2A subunits has concentration-dependent, reversible, and voltage-independent properties. The major binding sites were V169 of the NR1a subunit and N466 of the NR2A subunit. (4) Conclusion: Ergotamine effectively inhibited NR1a/NR2A subunit among the subtypes of NMDAR. This inhibition effect can prevent excessive Ca<sup>2+</sup> influx, which prevents neuronal death.
first_indexed 2024-03-09T10:02:22Z
format Article
id doaj.art-4c91b517e51742169cbafc2cfa3e2304
institution Directory Open Access Journal
issn 2076-3921
language English
last_indexed 2024-03-09T10:02:22Z
publishDate 2022-07-01
publisher MDPI AG
record_format Article
series Antioxidants
spelling doaj.art-4c91b517e51742169cbafc2cfa3e23042023-12-01T23:20:00ZengMDPI AGAntioxidants2076-39212022-07-01118147110.3390/antiox11081471The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate ReceptorsShinhui Lee0Sanung Eom1Khoa V. A. Nguyen2Jiwon Lee3Youngseo Park4Hye Duck Yeom5Junho H. Lee6Department of Biotechnology, Chonnam National University, Gwangju 61186, KoreaDepartment of Biotechnology, Chonnam National University, Gwangju 61186, KoreaDepartment of Biotechnology, Chonnam National University, Gwangju 61186, KoreaDepartment of Biotechnology, Chonnam National University, Gwangju 61186, KoreaDepartment of Biotechnology, Chonnam National University, Gwangju 61186, KoreaGoPath Laboratories, Buffalo Grove, IL 60089, USADepartment of Biotechnology, Chonnam National University, Gwangju 61186, Korea(1) Background: The N-methyl-D-aspartate receptors (NMDARs) mediate fast excitatory currents leading to depolarization. Postsynaptic NMDARs are ionotropic glutamate receptors that mediate excitatory glutamate or glycine signaling in the CNS and play a primary role in long-term potentiation, which is a major form of use-dependent synaptic plasticity. The overstimulation of NMDARs mediates excessive Ca<sup>2+</sup> influx to postsynaptic neurons and facilitates more production of ROS, which induces neuronal apoptosis. (2) Methods: To confirm the induced inward currents by the coapplication of glutamate and ergotamine on NMDARs, a two-electrode voltage clamp (TEVC) was conducted. The ergotamine-mediated inhibitory effects of NR1a/NR2A subunits were explored among four different kinds of recombinant NMDA subunits. In silico docking modeling was performed to confirm the main binding site of ergotamine. (3) Results: The ergotamine-mediated inhibitory effect on the NR1a/NR2A subunits has concentration-dependent, reversible, and voltage-independent properties. The major binding sites were V169 of the NR1a subunit and N466 of the NR2A subunit. (4) Conclusion: Ergotamine effectively inhibited NR1a/NR2A subunit among the subtypes of NMDAR. This inhibition effect can prevent excessive Ca<sup>2+</sup> influx, which prevents neuronal death.https://www.mdpi.com/2076-3921/11/8/1471NMDAN-methyl-D-aspartateergotamineergot alkaloidantioxidantneuronal disease
spellingShingle Shinhui Lee
Sanung Eom
Khoa V. A. Nguyen
Jiwon Lee
Youngseo Park
Hye Duck Yeom
Junho H. Lee
The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors
Antioxidants
NMDA
N-methyl-D-aspartate
ergotamine
ergot alkaloid
antioxidant
neuronal disease
title The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors
title_full The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors
title_fullStr The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors
title_full_unstemmed The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors
title_short The Application of the Neuroprotective and Potential Antioxidant Effect of Ergotamine Mediated by Targeting N-Methyl-D-Aspartate Receptors
title_sort application of the neuroprotective and potential antioxidant effect of ergotamine mediated by targeting n methyl d aspartate receptors
topic NMDA
N-methyl-D-aspartate
ergotamine
ergot alkaloid
antioxidant
neuronal disease
url https://www.mdpi.com/2076-3921/11/8/1471
work_keys_str_mv AT shinhuilee theapplicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT sanungeom theapplicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT khoavanguyen theapplicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT jiwonlee theapplicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT youngseopark theapplicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT hyeduckyeom theapplicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT junhohlee theapplicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT shinhuilee applicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT sanungeom applicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT khoavanguyen applicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT jiwonlee applicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT youngseopark applicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT hyeduckyeom applicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors
AT junhohlee applicationoftheneuroprotectiveandpotentialantioxidanteffectofergotaminemediatedbytargetingnmethyldaspartatereceptors